title: Orthopaedics: Structural support.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Berglund
mesh_terms: D050071:Bone Density Conservation Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001847:Bone Diseases / Q000150:complications / Q000188:drug therapy / Q000473:pathology; D001859:Bone Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000556:secondary; D001897:Boronic Acids / Q000494:pharmacology / Q000627:therapeutic use; D000069286:Bortezomib; D004164:Diphosphonates / Q000494:pharmacology / Q000627:therapeutic use; D012968:Etidronic Acid / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000378:metabolism; D058498:Kyphoplasty; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology*; D010006:Osteoblasts / Q000187:drug effects / Q000473:pathology / Q000502:physiology; D010010:Osteoclasts / Q000187:drug effects / Q000473:pathology / Q000502:physiology; D010012:Osteogenesis / Q000187:drug effects; D061988:Proteasome Inhibitors; D011719:Pyrazines / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: D050071:Bone Density Conservation Agents; D001897:Boronic Acids; C501126:DKK1 protein, human; D004164:Diphosphonates; D036341:Intercellular Signaling Peptides and Proteins; D061988:Proteasome Inhibitors; D011719:Pyrazines; D000069286:Bortezomib; D012968:Etidronic Acid